A single enzyme plays a critical role in helping the body effectively fight viral infection

August 15, 2012
Immunology: A key checkpoint against infection
© iStockphoto.com/Eraxion

The body’s initial response to invading bacteria or viruses is mediated by the innate immune system, wherein cells secrete signaling factors called cytokines that promote inflammation and stimulate a generalized counterattack against targets perceived as ‘foreign’. The protein Toll-like receptor 3 (TLR3), for instance, helps initiate the innate immune response against viruses.

Kong-Peng Lam at the A*STAR Bioprocessing Technology Institute and co-workers have now gained insights into how TLR3 helps ‘rally the troops’. They showed that TLR3 recognizes viral genetic material, and subsequently undergoes activation via the enzymatic addition of phosphate chemical groups to specific amino acids — a process known as phosphorylation.

The researchers identified Bruton’s tyrosine kinase (BTK) as a TLR3-activating in this pathway. They found BTK to be a promising candidate based on its prominent role in immune function: mutations in this gene result in X-linked agammaglobulinemia (XLA), a disease characterized by failures in B cell production and function. “These patients are also very susceptible to recurrent bacterial and ,” says Lam, “which suggested that BTK might be involved in innate immunity.”

To test their hypothesis, the researchers injected mice with polyribocytidylic acid, a molecule that resembles viral RNA and triggers an antiviral immune response. In normal mice, this treatment can trigger a strong inflammatory overreaction that leads to fatal septic shock. However, both BTK-deficient and TLR3-deficient mice proved resistant to septic shock, suggesting these two molecules work together in a common pathway. TLR3 activation also generates signals that stimulate production of the immunostimulatory molecule interferon β, but the absence of BTK effectively crippled this response in mice. Accordingly, BTK-deficient mice proved far less capable of clearing dengue virus from their system than wild-type animals.

Biochemical experiments clearly demonstrated that BTK was required for the phosphorylation of TLR3. Following activation, TLR3 binds to TRIF, an ‘adapter’ protein that allows it to interact with various other signaling factors. However, without BTK, TLR3 fails to undergo phosphorylation. As a result, TRIF cannot bind to downstream signaling molecules, thus stopping the signaling cascade in its tracks (see image).

Lam now hopes to determine whether BTK represents a general component of innate immunity outside of the TLR3 pathway. In the meantime, he suggests that BTK-targeting drugs could prove a useful tool for immunomodulation. “Conceptually, BTK inhibitors could be used to dampen exaggerated immune responses when the host ‘cytokine storm’ is a curse rather than a blessing, such as in the case of SARS coronavirus infection,” says Lam.

Explore further: Scientists discover 'switch' to boost anti-viral response to fight infectious diseases

More information: Lee, K. G. et al. Bruton’s tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response. Proceedings of the National Academy of Sciences 109, 5791–5796 (2012). dx.doi.org/10.1073/pnas.1119238109

Related Stories

Who goes there? Novel complex senses viral infection

June 23, 2011

Double-stranded (ds) RNA viruses are a diverse group of viruses that include rotaviruses, a common cause of gastroenteritis. The ability of the immune system to detect and destroy viruses is critical for human health and ...

Recommended for you

Researchers reveal role of gene in IBD

April 26, 2017

Inside a healthy gut, bacteria and immune cells maintain a delicate balance. If that balance is disturbed, a condition called inflammatory bowel disease or IBD can result. Patients with IBD can experience diarrhea, abdominal ...

When liver immune cells turn bad

April 21, 2017

A high-fat diet and obesity turn "hero" virus-fighting liver immune cells "rogue", leading to insulin resistance, a condition that often results in type 2 diabetes, according to research published today in Science Immunology.

Researchers unlock an immunity 'black box'

April 18, 2017

A research team led by St. Jude Children's Research Hospital immunologists has revealed a previously unknown immune machinery that goes awry to trigger the inflammatory disease neutrophilic dermatosis. Neutrophilic dermatoses ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.